PBRM1 and BAP1 expression in renal cell carcinoma

被引:0
|
作者
Kuthi, L. [1 ]
Fallmann, E. [1 ]
Jenei, A. [1 ]
Posfai, B. [1 ]
Maraz, A. [1 ]
机构
[1] Univ Szeged, Dept Pathol, Szeged, Hungary
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
OFP-13-010
引用
收藏
页码:S44 / S44
页数:1
相关论文
共 50 条
  • [31] CORRELATION OF BAP1 AND PBRM1 MUTATIONAL STATUS AT TIME OF CYTOREDUCTIVE NEPHRECTOMY WITH SURVIVAL
    Manley, Brandon J.
    Casuscelli, Jozefina
    Tennenbaum, Daniel M.
    Becerra, Maria F.
    Redzematovic, Almedina
    Arcila, Maria E.
    Russo, Paul
    Coleman, Jonathan A.
    Voss, Martin H.
    Feldman, Darren R.
    Motzer, Robert J.
    Hsieh, James J.
    Hakimi, A. Ari
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1032 - E1033
  • [32] Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors
    Eckel-Passow, Jeanette E.
    Serie, Daniel J.
    Cheville, John C.
    Ho, Thai H.
    Harrington, Sue M.
    Hilton, Tracy
    Lohse, Christine
    Shreders, Amanda
    Kapur, Payal
    Brugarolas, James
    Thompson, R. Houston
    Leibovich, Bradley C.
    Kwon, Eugene D.
    Joseph, Richard W.
    Parker, Alexander S.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [33] VHL, PBRM1, and BAP1 mutation variants and response to first-line therapies in patients with metastatic clear-cell renal cell carcinoma (mRCC)
    Zhu, Jessica
    Hu, Junxiao
    Lam, Elaine T.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [34] A germline mutation in PBRM1 predisposes to renal cell carcinoma
    Benusiglio, Patrick R.
    Couve, Sophie
    Gilbert-Dussardier, Brigitte
    Deveaux, Sophie
    Le Jeune, Helene
    Da Costa, Melanie
    Fromont, Gaelle
    Memeteau, Francoise
    Yacoub, Mokrane
    Coupier, Isabelle
    Leroux, Dominique
    Mejean, Arnaud
    Escudier, Bernard
    Giraud, Sophie
    Gimenez-Roqueplo, Anne-Paule
    Blondel, Christophe
    Frouin, Eric
    Teh, Bin T.
    Ferlicot, Sophie
    Bressac-de Paillerets, Brigitte
    Richard, Stephane
    Gad, Sophie
    JOURNAL OF MEDICAL GENETICS, 2015, 52 (06) : 426 - 430
  • [35] PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma—a case report
    Mitsuru Tamura
    Kiyotaka Yokogami
    Takashi Watanabe
    Tomoki Kawano
    Junichiro Muta
    Shinji Yamashita
    Nobuyuki Oguri
    Yuichiro Sato
    Hideo Takeshima
    Brain Tumor Pathology, 2023, 40 : 40 - 44
  • [36] Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma
    Gossage, Lucy
    Murtaza, Muhammed
    Slatter, Andrew F.
    Lichtenstein, Conrad P.
    Warren, Anne
    Haynes, Beverley
    Marass, Francesco
    Roberts, Ian
    Shanahan, Susan J.
    Claas, Andreas
    Dunham, Andrew
    May, Andrew P.
    Rosenfeld, Nitzan
    Forshew, Tim
    Eisen, Tim
    GENES CHROMOSOMES & CANCER, 2014, 53 (01): : 38 - 51
  • [37] High concordance of BAP1 and PBRM1 expression in patient-matched primary and metastatic ccRCC tumors.
    Shreders, Amanda
    Joseph, Richard Wayne
    Serie, Daniel
    Kapur, Payal
    Ho, Thai Huu
    Eckel-Passow, Jeanette
    Brugarolas, James
    Parker, Alexander S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [38] The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Moon, Kyung Chul
    Kwak, Cheol
    Kim, Hyeon Hoe
    Keam, Bhumsuk
    Kim, Tae Min
    Heo, Dae Seog
    JOURNAL OF UROLOGY, 2015, 194 (04): : 1112 - 1119
  • [39] Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
    Aili, Abudureyimujiang
    Wen, Jie
    Xue, Lixiang
    Wang, Junjie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] PBRM1, SETD2 and BAP1-the trinity of 3p in clear cell renal cell carcinoma
    Walton, Joseph
    Lawson, Keith
    Prinos, Panagiotis
    Finelli, Antonio
    Arrowsmith, Cheryl
    Ailles, Laurie
    NATURE REVIEWS UROLOGY, 2023, 20 (02) : 96 - 115